NASDAQ: AHGAkso Health Group Stock
$1.67+0.08 (+5.03%)
Updated Oct 30, 2025
AHG Price
$1.67
Fair Value Price
N/A
Market Cap
$921.79M
52 Week Low
$0.74
52 Week High
$2.35
P/E
-3.48x
P/B
4.63x
P/S
22.77x
PEG
N/A
Dividend Yield
N/A
Revenue
$14.78M
Earnings
-$134.98M
Gross Margin
-1.9%
Operating Margin
-1,121.81%
Profit Margin
-913.4%
Debt to Equity
0.08
Operating Cash Flow
$1M
Beta
1.27
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
AHG Overview
Akso Health Group operates a social e-commerce mobile platform in China. The company operates Xiaobai Maimai App, which offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, etc. It also offers consultancy and information technology support services; and trades in branded products, as well as promotes products. The company was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021. Akso Health Group was founded in 2014 and is headquartered in Beijing, China. As of July 13, 2021, Akso Health Group operates as a subsidiary of Webao Limited.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine AHG's potential to beat the market
- AHG doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Medical Distribution
Industry Rating
A
AHG
RankedUnranked of 7
RankedUnranked of 7
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $189.84 | B | |
| $825.53 | B | |
| $2.27 | B |
Be the first to know about important AHG news, forecast changes, insider trades & much more!
AHG News
Overview
Due Diligence Score
–
Industry Average (29)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how AHG scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
AHG is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
AHG is good value based on its book value relative to its share price (4.63x), compared to the US Medical Distribution industry average (408.87x)
P/B vs Industry Valuation
AHG is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 35 more AHG due diligence checks available for Premium users.
Valuation
AHG fair value
Fair Value of AHG stock based on Discounted Cash Flow (DCF)
Price
$1.67
Fair Value
$5.21
Undervalued by
67.96%
AHG is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
AHG price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-3.48x
Industry
31.88x
Market
40.85x
AHG price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
4.63x
Industry
408.87x
AHG is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
AHG's financial health
Profit margin
Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
AHG's Earnings (EBIT) of -$165.78M... subscribe to Premium to read more.
Interest Coverage Financials
AHG's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$215.0M
Liabilities
$15.8M
Debt to equity
0.08
AHG's short-term assets ($196.12M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
AHG's short-term assets ($196.12M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
AHG's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
AHG's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
AHG's operating cash flow ($1.18M)... subscribe to Premium to read more.
Debt Coverage Financials
AHG vs Medical Distribution Stocks
Akso Health Group Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.